Literature DB >> 19635412

pHLIP-mediated translocation of membrane-impermeable molecules into cells.

Damien Thévenin1, Ming An, Donald M Engelman.   

Abstract

Our goal is to define the properties of cell-impermeable cargo molecules that can be delivered into cells by pH (Low) Insertion Peptide (pHLIP), which can selectively target tumors in vivo based on their acidity. Using biophysical methods and fluorescence microscopy, we show that pHLIP can successfully deliver polar and membrane-impermeable cyclic peptides linked to its C terminus through the membranes of lipid vesicles and cancer cells. Our results also indicate that the translocation of these cargo molecules is pH dependent and mediated by transmembrane helix formation. Since a broad range of cell-impermeable molecules is excluded from discovery efforts because they cannot traverse membranes on their own, we believe that pHLIP has the potential to expand therapeutic options for acidic tissues such as tumors and sites of inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635412      PMCID: PMC2741147          DOI: 10.1016/j.chembiol.2009.06.006

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  49 in total

1.  A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers.

Authors:  Yana K Reshetnyak; Michael Segala; Oleg A Andreev; Donald M Engelman
Journal:  Biophys J       Date:  2007-06-08       Impact factor: 4.033

2.  A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.

Authors:  E Vivès; P Brodin; B Lebleu
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

3.  Fluorescence and the location of tryptophan residues in protein molecules.

Authors:  E A Burstein; N S Vedenkina; M N Ivkova
Journal:  Photochem Photobiol       Date:  1973-10       Impact factor: 3.421

4.  The third helix of the Antennapedia homeodomain translocates through biological membranes.

Authors:  D Derossi; A H Joliot; G Chassaing; A Prochiantz
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

5.  Colorimetric determination of phospholipids with ammonium ferrothiocyanate.

Authors:  J C Stewart
Journal:  Anal Biochem       Date:  1980-05-01       Impact factor: 3.365

6.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.

Authors:  L E Gerweck; K Seetharaman
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

7.  Bilayer interactions of pHLIP, a peptide that can deliver drugs and target tumors.

Authors:  Manuela Zoonens; Yana K Reshetnyak; Donald M Engelman
Journal:  Biophys J       Date:  2008-03-21       Impact factor: 4.033

8.  Fluorescence assay for phospholipid membrane asymmetry.

Authors:  J C McIntyre; R G Sleight
Journal:  Biochemistry       Date:  1991-12-24       Impact factor: 3.162

Review 9.  GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery.

Authors:  Weijun Li; François Nicol; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2004-04-23       Impact factor: 15.470

Review 10.  Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.

Authors:  Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

View more
  37 in total

1.  pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation.

Authors:  Ming An; Dayanjali Wijesinghe; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-03       Impact factor: 11.205

2.  Roles of carboxyl groups in the transmembrane insertion of peptides.

Authors:  Francisco N Barrera; Dhammika Weerakkody; Michael Anderson; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman
Journal:  J Mol Biol       Date:  2011-08-23       Impact factor: 5.469

3.  A "Smart" ¹²⁸Xe NMR Biosensor for pH-Dependent Cell Labeling.

Authors:  Brittany A Riggle; Yanfei Wang; Ivan J Dmochowski
Journal:  J Am Chem Soc       Date:  2015-04-20       Impact factor: 15.419

4.  Aggregation Behavior of pHLIP in Aqueous Solution at Low Concentrations: A Fluorescence Study.

Authors:  Bhagyashree D Rao; Hirak Chakraborty; Sandro Keller; Amitabha Chattopadhyay
Journal:  J Fluoresc       Date:  2018-06-29       Impact factor: 2.217

5.  Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.

Authors:  Alexander A Svoronos; Raman Bahal; Mohan C Pereira; Francisco N Barrera; John C Deacon; Marcus Bosenberg; Daniel DiMaio; Peter M Glazer; Donald M Engelman
Journal:  Mol Pharm       Date:  2020-01-13       Impact factor: 4.939

6.  Inhibiting Epidermal Growth Factor Receptor Dimerization and Signaling Through Targeted Delivery of a Juxtamembrane Domain Peptide Mimic.

Authors:  Janessa Gerhart; Anastasia F Thévenin; Elizabeth Bloch; Kelly E King; Damien Thévenin
Journal:  ACS Chem Biol       Date:  2018-08-31       Impact factor: 5.100

7.  Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.

Authors:  Kelly E Burns; Matthew K Robinson; Damien Thévenin
Journal:  Mol Pharm       Date:  2015-03-13       Impact factor: 4.939

Review 8.  Applications of pHLIP Technology for Cancer Imaging and Therapy.

Authors:  Linden C Wyatt; Jason S Lewis; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman
Journal:  Trends Biotechnol       Date:  2017-04-21       Impact factor: 19.536

9.  Membrane physical properties influence transmembrane helix formation.

Authors:  Francisco N Barrera; Justin Fendos; Donald M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

10.  Peptide targeting and imaging of damaged lung tissue in influenza-infected mice.

Authors:  Na Li; Lu Yin; Damien Thévenin; Yoshiyuki Yamada; Gino Limmon; Jianzhu Chen; Vincent Tk Chow; Donald M Engelman; Bevin P Engelward
Journal:  Future Microbiol       Date:  2013-02       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.